CD8A and melanoma: It is also noteworthy that a single administration of Cl-IB-MECA may augment the protective immunity in the melanoma, by enhancing tumor infiltration of CD8+ T cells, which, in turn, are driven to induce a Th1-like and cytotoxic immune microenvironment.